Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/05/2013US20130323301 Enhanced cancer treatment and monitoring using recombinant vectors
12/05/2013US20130323300 Therapeutic composition for treatment of glioblastoma
12/05/2013US20130323298 Amphoteric Liposome Formulation
12/05/2013US20130323288 Pharmaceutical formulation for bedwetting and method of use thereof
12/05/2013US20130323286 Synthesis of r-n-methylnaltrexone
12/05/2013US20130323284 USE OF mTOR INHIBITORS TO TREAT BACTERIAL INFECTION
12/05/2013US20130323283 Compositions and methods for treating foxp3+ treg related diseases
12/05/2013US20130323271 Nitric oxide donor neprilysin inhibitors
12/05/2013US20130323269 Methods and compositions for delivery of active agents
12/05/2013US20130323258 Compositions and methods for treating cardivascular disease
12/05/2013US20130323254 Therapeutic anti-tirc7 antibodies for use in immune related and other diseases
12/05/2013US20130323242 Compositions comprising an anti-pdgf aptamer and a vegf antagonist
12/05/2013US20130323239 Modulation of pilr receptors to treat sepsis
12/05/2013US20130323231 Treatment and prognosis of solid tumour cancers
12/05/2013US20130323230 Treatment of myelosuppression
12/05/2013US20130323228 Cleansing and anti-acne composition
12/05/2013US20130323226 Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer
12/05/2013US20130323217 Compositions and methods for the controlled repopulation of gram-negative bacteria in the colon
12/05/2013US20130323216 Synbiotic mixture
12/05/2013US20130323203 Inhibitors of flaviviridae viruses
12/05/2013US20130323198 Use of AMG 900 for the Treatment of Cancer
12/05/2013US20130323196 Method for mobilizing stem and/or progenitor cells
12/05/2013US20130323189 Antifungal nail coat and method of use
12/05/2013US20130323184 Method Of Providing Fast Relief To A User Of A Nicotine Chewing Gum
12/05/2013US20130323183 Absorbent dressings with painkilling activity
12/05/2013US20130323179 Nanocrystals, compositions, and methods that aid particle transport in mucus
12/05/2013US20130320592 Process for the production of an abuse-proofed dosage form
12/05/2013US20130319595 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
12/05/2013US20130319411 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
12/05/2013DE102012104814A1 New RNA-molecule having a sequence with a specific length, useful as a target molecule for producing pharmaceutical composition for the treatment of infectious diseases
12/05/2013DE102012010774A1 Pharmazeutische Pemetrexed-Lösung Pharmaceutical pemetrexed solution
12/05/2013CA2875417A1 O/w-emulsion-type topical pharmaceutical compositions containing a retinoid
12/05/2013CA2875348A1 Chemical suppressors of neurotoxicity in synucleinopathic diseases
12/05/2013CA2875189A1 Genotype- or phenotype-based drug formulation
12/05/2013CA2875145A1 Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
12/05/2013CA2875132A1 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases
12/05/2013CA2875080A1 Prodrug of fluorine-containing amino acid
12/05/2013CA2875069A1 Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
12/05/2013CA2875063A1 Method of synthesising sulforaphane
12/05/2013CA2875012A1 Novel compounds and compositions for treatment of breathing control disorders or diseases
12/05/2013CA2874987A1 Heterocyclic compound
12/05/2013CA2874967A1 Pteridines as fgfr inhibitors
12/05/2013CA2874961A1 Antispasmodic 1,2-diols and 1,2,3-triols
12/05/2013CA2874938A1 Heterocycles capable of modulating t-cell responses, and methods of using same
12/05/2013CA2874919A1 Bicyclic heterocycles capable of modulating t-cell responses, and methods of using same
12/05/2013CA2874911A1 New compounds
12/05/2013CA2874905A1 Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients
12/05/2013CA2874881A1 Method of treating scedosporium spp. infection
12/05/2013CA2874780A1 Inflammation-enabling polypeptides and uses thereof
12/05/2013CA2874779A1 Pharmaceutical composition of entecavir and process of manufacturing
12/04/2013EP2669377A2 Modified iRNA agents
12/04/2013EP2669292A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof
12/04/2013EP2669289A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
12/04/2013EP2669288A1 New monosaccharide derivatives and biological applications thereof
12/04/2013EP2669286A1 Spiro tetrahydro-benzothiophen derivatives useful for the treatment of neurodegenerative diseases
12/04/2013EP2669285A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
12/04/2013EP2669283A1 Oxazolidinone derivative having 7-membered hetero ring
12/04/2013EP2669280A1 Bicyclic compound and use thereof for medical purposes
12/04/2013EP2669279A1 Bicyclic compound and use thereof for medical purposes
12/04/2013EP2669276A1 Ornithine- and lysine-derivatives for the treatment of pain
12/04/2013EP2669274A1 Topical antifungal agent
12/04/2013EP2669273A1 Process for preparing atazanavir bisulfate and novel forms
12/04/2013EP2669272A1 Indole derivative and pharmacologically acceptable salt of same
12/04/2013EP2669271A1 Indole derivative, and pharmacologically acceptable salt thereof
12/04/2013EP2669270A1 Ring-fused compound
12/04/2013EP2669267A1 Compositions and methods for treating hyperproliferative disorders
12/04/2013EP2668954A1 Extraction method, total saponin and use of ilex kudingcha c.j.tseng leaves
12/04/2013EP2668953A1 Pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate and/or an inhibitor of uric acid synthesis
12/04/2013EP2668952A2 Aqueous formulations of bisphosphonates, vitamin D and benzyl alcohol suitable for subcutaneous or intramuscular use
12/04/2013EP2668951A1 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor
12/04/2013EP2668950A1 Anti-leishmanial compound and anti-leishmanial drug
12/04/2013EP2668949A1 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
12/04/2013EP2668948A1 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
12/04/2013EP2668947A1 Induction of arteriogenesis with a no-donor
12/04/2013EP2668946A1 Anti-leishmanial compound and anti-leishmanial drug
12/04/2013EP2668945A1 Genotype and phenotype-based medicinal formulations
12/04/2013EP2668944A1 Aromatase activator
12/04/2013EP2668941A1 Novel dosage form and formulation of abediterol
12/04/2013EP2668939A1 Composition containing polyunsaturated fatty acid
12/04/2013EP2668851A1 Liver function-improving agent
12/04/2013EP2668274A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
12/04/2013EP2668198A1 Fgf receptor-activating 3-o-alkyl oligosaccharides, preparation thereof and therapeutic use thereof
12/04/2013EP2668191A2 Benzofuro[3,2-c]pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
12/04/2013EP2668190A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
12/04/2013EP2668189A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
12/04/2013EP2668188A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
12/04/2013EP2668187A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
12/04/2013EP2668186A1 Pharmaceutical composition comprising pyridone derivatives
12/04/2013EP2668185A1 Pharmaceutical composition comprising pyridone derivatives
12/04/2013EP2668184A1 Derivatives of azaindazole or diazaindazole type as medicament
12/04/2013EP2668183A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
12/04/2013EP2668182A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
12/04/2013EP2668181A1 Pyrazole compounds as crth2 antagonists
12/04/2013EP2668180A2 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
12/04/2013EP2668179A1 New 5-alkynyl-pyridines
12/04/2013EP2668178A1 New 5-alkynyl-pyridines
12/04/2013EP2668177A1 Substituted pyridinyl-pyrimidines and their use as medicaments
12/04/2013EP2668169A1 Tetrazole compounds and methods of making and using same
12/04/2013EP2668168A1 COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION
12/04/2013EP2668167A1 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 7860